Jennifer F. Tseng, MD, MPH, FACS, has joined the
Roberta and Stephen R. Weiner Department of Surgery as Chief of
Surgical Oncology and Clinical Co-Director for Surgery at the Beth Israel Deaconess Medical Center Cancer Center.
Tseng comes to BIDMC from UMass Memorial Medical Center in Worcester where she was an attending surgeon with a clinical focus on pancreatic and upper gastrointestinal cancers. She was also an Associate Professor of Surgery, Cancer Biology and Quantitative Health Sciences at the University of Massachusetts Medical School.
Tseng, a surgical oncologist and gastrointestinal surgeon, leads the BIDMC Cancer Center in the multidisciplinary care of solid tumors. Her practice encompasses the upper GI tract, including hepato-pancreatic-biliary, gastric and upper intestinal surgery.
A graduate of the University of California, San Francisco Medical School, Tseng completed a residency in general surgery at Massachusetts General Hospital and a research fellowship in molecular medicine at Harvard Medical School/Children's Hospital Boston. She completed a clinical fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center in Houston. Tseng also holds a master's degree in public health from the Harvard School of Public Health.
Tseng's research interests include developing models for cancer treatment sequencing strategies, cancer biomarkers, and healthcare disparities and outcomes research.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently
ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit